Profile of Female Hyperandrogenism at the Medical Clinic II: About 19 Cases

    January 2023 in “ Open Journal of Endocrine and Metabolic Diseases ”
    Michel Assane Ndour, Demba Diédhiou, D. Sow, I. Diallo, Mouhamed Dieng, Fatou Leïty Mbodj, Julie Borges Preira, Fatou Kiné Gadji, Muriel Diembou, Fagueye Ndiaye, El Hadj Mouhamadou Moustapha Thioye, Charles Halim, A. Sarr, Maïmouna Ndour Mbaye
    Image of study
    TLDR Hyperandrogenism is a common hormonal disorder in women, often linked to PCOS.
    The study "Profile of Female Hyperandrogenism at the Medical Clinic II: About 19 Cases" involved 19 women of childbearing age over 22 months, with an average age of 25.3 years. The most common symptoms were menstrual disorders (94.7%), hirsutism (78.9%), and pelvic pain (10.5%). All patients had hirsutism, with 52.6% having a non-pathological score. Polymicrocystic ovarian syndrome (PCOS) was found in 68.4% of patients, making it the most common cause of hyperandrogenism. Other symptoms included acne (36.8%), hyperseborrhea (57.9%), and acanthosis nigricans (47.4%). The study concluded that hyperandrogenism is a common endocrine abnormality in women, with further large-scale studies needed to better understand its prevalence and characteristics.
    Discuss this study in the Community →

    Research cited in this study

    10 / 10 results

    Related Community Posts Join

    6 / 7 results

      community DHT levels after 4 weeks of Fina and 8 weeks of Fina + 4 weeks of Duta

      in Update  37 upvotes 6 years ago
      The user reported early stage diffuse hair thinning and increased DHT levels after 4 weeks on Finasteride and 8 weeks on Finasteride plus 4 weeks on Dutasteride, despite the medications being authentic and stored properly. They are considering increasing their Dutasteride dosage due to the lack of side effects and are unsure if the treatment is helping their hair.

      community Proposed new pathogenesis model for androgenetic alopecia (AGA)

      in Research/Science  8 upvotes 1 year ago
      The conversation discusses a new model for understanding androgenetic alopecia (AGA), linking it to dietary and lifestyle factors similar to PCOS, and highlighting the role of DHT, vascular damage, and inflammation. Treatments mentioned include Minoxidil, finasteride, and RU58841.

      community Spironolactine Update: 2 months (34, Female)

      in Female  22 upvotes 8 years ago
      A female user's experience using Spironolactone to treat Female Pattern Hair Loss (FPHL) and Androgenic Alopecia, as well as discussing the effectiveness of the drug at different dosages.

      community Quit vaping/smoking = 80% less loss

      in Research/Science  235 upvotes 1 year ago
      Quitting vaping significantly reduced hair loss for a user who was a heavy vaper and also taking finasteride. Some participants suggest nicotine's vasoconstrictive properties may worsen hair loss, while others share personal anecdotes of hair improvement after quitting smoking or vaping.

    Related Research

    4 / 4 results